The implants have been associated with anaplastic large-cell lymphoma, a rare cancer of the immune system. A majority of the cases occurred in women with textured implants manufactured by Allergan. Many other countries have banned the use of textured implants.
However, the FDA said May 2 that there was not enough evidence to justify banning the implants.
“At this time, the FDA does not believe that, on the basis of all available data and information, the device meets the banning standard set forth in the federal Food, Drug and Cosmetic Act,” the FDA said.
More articles on supply chain:
Free 1-day Prime shipping coming soon, Amazon says
A generic version of Narcan, a device for ADHD & more: 6 recent FDA approvals
How the US healthcare system can tackle its sustainability problem
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
